State Street’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $235M | Sell |
|
|||||
|
2024
Q4 | $157M | Buy |
|
|||||
|
2024
Q3 | $136M | Buy |
|
|||||
|
2024
Q2 | $123M | Sell |
|
|||||
|
2024
Q1 | $155M | Buy |
|
|||||
|
2023
Q4 | $159M | Buy |
|
|||||
|
2023
Q3 | $111M | Buy |
|
|||||
|
2023
Q2 | $133M | Buy |
|
|||||
|
2023
Q1 | $110M | Buy |
|
|||||
|
2022
Q4 | $106M | Buy |
|
|||||
|
2022
Q3 | $92M | Buy |
|
|||||
|
2022
Q2 | $110M | Buy |
|
|||||
|
2022
Q1 | $110M | Buy |
|
|||||
|
2021
Q4 | $79.7M | Sell |
|
|||||
|
2021
Q3 | $58.3M | Buy |
|
|||||
|
2021
Q2 | $61.2M | Buy |
|
|||||
|
2021
Q1 | $50.3M | Sell |
|
|||||
|
2020
Q4 | $51.3M | Buy |
|
|||||
|
2020
Q3 | $36.4M | Buy |
|
|||||
|
2020
Q2 | $35M | Buy |
|
|||||
|
2020
Q1 | $19M | Buy |
|
|||||
|
2019
Q4 | $38.2M | Sell |
|
|||||
|
2019
Q3 | $8.64M | Buy |
|
|||||
|
2019
Q2 | $13M | Buy |
|
|||||
|
2019
Q1 | $12.1M | Sell |
|
|||||
|
2018
Q4 | $11.7M | Buy |
|
|||||
|
2018
Q3 | $21.8M | Buy |
|
|||||
|
2018
Q2 | $16.6M | Buy |
|
|||||
|
2018
Q1 | $19.1M | Sell |
|
|||||
|
2017
Q4 | $13.8M | Buy |
|
|||||
|
2017
Q3 | $11.6M | Sell |
|
|||||
|
2017
Q2 | $12.5M | Buy |
|
|||||
|
2017
Q1 | $14.8M | Sell |
|
|||||
|
2016
Q4 | $14.7M | Buy |
|
|||||
|
2016
Q3 | $12.6M | Buy |
|
|||||
|
2016
Q2 | $30.4M | Sell |
|
|||||
|
2016
Q1 | $23.1M | Buy |
|
|||||
|
2015
Q4 | $43.4M | Sell |
|
|||||
|
2015
Q3 | $47.3M | Buy |
|
|||||
|
2015
Q2 | $9.62M | Buy |
|
|||||
|
2015
Q1 | $6.01M | Buy |
|
|||||
|
2014
Q4 | $3.4M | Buy |
|
|||||
|
2014
Q3 | $2.43M | Buy |
|
|||||
|
2014
Q2 | $2.9M | Buy |
|
|||||
|
2014
Q1 | $278K | Buy |
|